Director/Senior Director/Executive Director - AAV R&D

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life‑changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world. Eli Lilly and Company is seeking an AAV R&D leader to join our team in San Francisco, CA. Come join the rapidly expanding Lilly Genetic Medicines team at Lilly! We are responsible for inventing, characterizing, and advancing novel genetic reagents for a myriad of clinical applications. Our team works cross‑functionally within our organization across multiple disease areas and platforms. Our goal is to deliver on the promise of gene therapy to patients around the world. Responsibilities Develop novel AAV therapies at Lilly by driving data‑based decisions for internal and external programs Develop and implement the organization’s strategic vision AAV, aligning with business goals Collaborate with executives and leaders to address key business challenges using experience in gene therapy Drive the creation and implementation of screening novel AAV technologies, including capsid screens, cargo R&D, and related technologies Ensure best practices in model development, validation, and deployment Stay updated on emerging trends and suggest innovative solutions Integrate genetic medicine delivery strategy into broader gene therapy strategy Present analytical insights and recommendations to senior executives clearly and concisely Lead and/or grow a team to develop AAV gene therapy assets Basic Requirements PhD with 10+ years of industry experience Additional Skills/Preferences Mastery of ophthalmology gene therapy Proven track record of successfully leading discovery and translational gene therapy programs and platforms Strong experience with AAV, viral vectors, high‑throughput screening, and translational R&D; deep understanding of AAV biology Exceptional problem‑solving and analytical thinking Strong leadership, communication, and mentoring skills Ability to translate complex biology into actionable business strategies Strong project management skills, with experience leading cross‑functional teams and driving initiatives from concept to execution Other up to 10-15% travel for conferences or training Compensation & Benefits Actual compensation will depend on a candidate’s education, experience, skills, and geographic location. The anticipated wage for this position is $163,500 – $281,600. Full‑time employees will also be eligible for a company bonus (depending, in part, on company and individual performance). Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company‑sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision, and prescription drug benefits; flexible benefits such as healthcare, dependent day‑care, and flexible spending accounts; life insurance and death benefits; certain time‑off and leave of absence benefits; and well‑being benefits including an employee assistance program, fitness benefits, and employee clubs and activities. Lilly is proud to be an EEO employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status. #J-18808-Ljbffr